New insights along the gut-liver axis in cardiometabolic disease

J.J. Witjes

New insights along the gut-liver axis in cardiometabolic disease

Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

Abstract

In this thesis we targeted the human gut microbiome for the development of therapeutic strategies in metabolic disorders. In chapter 3 we performed a randomized placebo-controlled cross-over study in individuals with the metabolic syndrome in which we showed that a single duodenal infusion of A. soehngenii improved peripheral glycemic control. In chapter 4 we studied the

Original language	English
Qualification	Doctor of Philosophy
Awarding Institution	University of Amsterdam
Supervisors/Advisors	Nieuwdorp, Max, Supervisor Beuers, Ulrich, Supervisor Holleboom, A.G. (Onno), Co-supervisor Nederveen, Aart, Co-supervisor Holleboom, A.G., Co-supervisor, External person
Award date	8 Dec 2023
Print ISBNs	9789464696387
Publication status	Published - 2023

Access to Document

Cite this

@phdthesis{11fde89f3ffc455791b0ed9f678d8908,

title = "New insights along the gut-liver axis in cardiometabolic disease",

abstract = "In this thesis we targeted the human gut microbiome for the development of therapeutic strategies in metabolic disorders. In chapter 3 we performed a randomized placebo-controlled cross-over study in individuals with the metabolic syndrome in which we showed that a single duodenal infusion of A. soehngenii improved peripheral glycemic control. In chapter 4 we studied the",

author = "J.J. Witjes",

year = "2023",

language = "English",

isbn = "9789464696387",

type = "Phd-Thesis - Research and graduation internal",

school = "University of Amsterdam",

}

TY - THES

T1 - New insights along the gut-liver axis in cardiometabolic disease

AU - Witjes, J.J.

PY - 2023

Y1 - 2023

N2 - In this thesis we targeted the human gut microbiome for the development of therapeutic strategies in metabolic disorders. In chapter 3 we performed a randomized placebo-controlled cross-over study in individuals with the metabolic syndrome in which we showed that a single duodenal infusion of A. soehngenii improved peripheral glycemic control. In chapter 4 we studied the

AB - In this thesis we targeted the human gut microbiome for the development of therapeutic strategies in metabolic disorders. In chapter 3 we performed a randomized placebo-controlled cross-over study in individuals with the metabolic syndrome in which we showed that a single duodenal infusion of A. soehngenii improved peripheral glycemic control. In chapter 4 we studied the

UR - https://pure.uva.nl/ws/files/146075436/Licentieovereenkomst_medeondertekend_.pdf

M3 - Phd-Thesis - Research and graduation internal

SN - 9789464696387

ER -

New insights along the gut-liver axis in cardiometabolic disease

Abstract

Access to Document

Other files and links

Cite this